321 related articles for article (PubMed ID: 9064322)
1. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting.
Frey A; Giannasca KT; Weltzin R; Giannasca PJ; Reggio H; Lencer WI; Neutra MR
J Exp Med; 1996 Sep; 184(3):1045-59. PubMed ID: 9064322
[TBL] [Abstract][Full Text] [Related]
2. Cholera toxin B-mediated targeting of lipid vesicles containing ganglioside GM1 to mucosal epithelial cells.
Lian T; Ho RJ
Pharm Res; 1997 Oct; 14(10):1309-15. PubMed ID: 9358541
[TBL] [Abstract][Full Text] [Related]
3. Accessibility of glycolipid and oligosaccharide epitopes on rabbit villus and follicle-associated epithelium.
Mantis NJ; Frey A; Neutra MR
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G915-23. PubMed ID: 10859221
[TBL] [Abstract][Full Text] [Related]
4. Grafting protein ligand monolayers onto the surface of microparticles for probing the accessibility of cell surface receptors.
Frey A; Meckelein B; Schmidt MA
Bioconjug Chem; 1999; 10(4):562-71. PubMed ID: 10411452
[TBL] [Abstract][Full Text] [Related]
5. Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model.
van der Lubben IM; van Opdorp FA; Hengeveld MR; Onderwater JJ; Koerten HK; Verhoef JC; Borchard G; Junginger HE
J Drug Target; 2002 Sep; 10(6):449-56. PubMed ID: 12575734
[TBL] [Abstract][Full Text] [Related]
6. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.
Yu RK; Usuki S; Itokazu Y; Wu HC
Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107
[TBL] [Abstract][Full Text] [Related]
7. M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery.
Kim SH; Jung DI; Yang IY; Kim J; Lee KY; Nochi T; Kiyono H; Jang YS
Eur J Immunol; 2011 Nov; 41(11):3219-29. PubMed ID: 21887786
[TBL] [Abstract][Full Text] [Related]
8. Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding.
Liljeqvist S; Ståhl S; Andréoni C; Binz H; Uhlén M; Murby M
J Immunol Methods; 1997 Dec; 210(2):125-35. PubMed ID: 9520296
[TBL] [Abstract][Full Text] [Related]
9. Fucosylation and protein glycosylation create functional receptors for cholera toxin.
Wands AM; Fujita A; McCombs JE; Cervin J; Dedic B; Rodriguez AC; Nischan N; Bond MR; Mettlen M; Trudgian DC; Lemoff A; Quiding-Järbrink M; Gustavsson B; Steentoft C; Clausen H; Mirzaei H; Teneberg S; Yrlid U; Kohler JJ
Elife; 2015 Oct; 4():e09545. PubMed ID: 26512888
[TBL] [Abstract][Full Text] [Related]
10. Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier.
Coria LM; Risso GS; Guaimas FF; Ferrero MC; Bruno L; Pasquevich KA; Cassataro J
J Control Release; 2019 Jan; 293():158-171. PubMed ID: 30496771
[TBL] [Abstract][Full Text] [Related]
11. Targeting of mucosal vaccines to Peyer's patch M cells.
Frey A; Neutra MR
Behring Inst Mitt; 1997 Feb; (98):376-89. PubMed ID: 9382762
[TBL] [Abstract][Full Text] [Related]
12. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1), apically expressed on human colonic M cells, are potential receptors for microbial adhesion.
Baranov V; Hammarström S
Histochem Cell Biol; 2004 Feb; 121(2):83-9. PubMed ID: 14758482
[TBL] [Abstract][Full Text] [Related]
14. Interactions of viruses and microparticles with apical plasma membranes of M cells: implications for human immunodeficiency virus transmission.
Neutra MR
J Infect Dis; 1999 May; 179 Suppl 3():S441-3. PubMed ID: 10099115
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction between cholera toxin and dendritic cells is required for oral adjuvant activity.
Gustafsson T; Hua YJ; Dahlgren MW; Livingston M; Johansson-Lindbom B; Yrlid U
Eur J Immunol; 2013 Jul; 43(7):1779-88. PubMed ID: 23649516
[TBL] [Abstract][Full Text] [Related]
16. The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces.
Helander A; Silvey KJ; Mantis NJ; Hutchings AB; Chandran K; Lucas WT; Nibert ML; Neutra MR
J Virol; 2003 Jul; 77(14):7964-77. PubMed ID: 12829836
[TBL] [Abstract][Full Text] [Related]
17. Entry sites for oral vaccines and drugs: A role for M cells, enterocytes and dendritic cells?
Kaiserlian D; Etchart N
Semin Immunol; 1999 Jun; 11(3):217-24. PubMed ID: 10381867
[TBL] [Abstract][Full Text] [Related]
18. Receptor mediated targeting of M-cells.
Tyrer PC; Ruth Foxwell A; Kyd JM; Otczyk DC; Cripps AW
Vaccine; 2007 Apr; 25(16):3204-9. PubMed ID: 17276559
[TBL] [Abstract][Full Text] [Related]
19. Brush cells of the mouse intestine possess a specialized glycocalyx as revealed by quantitative lectin histochemistry. Further evidence for a sensory function.
Gebhard A; Gebert A
J Histochem Cytochem; 1999 Jun; 47(6):799-808. PubMed ID: 10330456
[TBL] [Abstract][Full Text] [Related]
20. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
